Thomas M. Wishart

6.2k citations

80 papers · 3.2k indexed · h-index 31

Molecular Biology top 5%
Cellular and Molecular Neuroscience top 2%
Genetics top 1%
Physiology top 5%
Neurology top 5%

Co-authors: Thomas H. Gillingwater Samantha L. Eaton Maica Llavero Hurtado Simon H. Parson Douglas J. Lamont Karla J. Oldknow Colin Farquharson Sarah L. Roche
Topics: Neurogenetic and Muscular Disorders Research (17 papers)Alzheimer's disease research and treatments (13 papers)RNA modifications and cancer (13 papers)
Cited by: Genetics Cellular and Molecular Neuroscience Developmental Neuroscience
Journals: Journal of Clinical Investigation Nature Communications Journal of Neuroscience
Partner nations: United Kingdom United States Germany

In The Last Decade

Thomas M. Wishart

76 papers receiving 3.2k citations

Peers

Countries citing papers authored by Thomas M. Wishart

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Wishart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Wishart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Wishart more than expected).

Fields of papers citing papers by Thomas M. Wishart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Wishart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Wishart. The network helps show where Thomas M. Wishart may publish in the future.

Co-authorship network of co-authors of Thomas M. Wishart

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Wishart. A scholar is included among the top collaborators of Thomas M. Wishart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Wishart. Thomas M. Wishart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA 2025 ·Human Molecular Genetics ·(unknown),Rachel Kline,(unknown),(unknown),Adrian Thomson,Douglas J. Lamont,Gillian A. Gray,Thomas M. Wishart,Lyndsay M. Murray	2
2	Distinct Molecular Profiles Underpin Mild-To-Moderate Equine Asthma Cytological Profiles 2024 ·Cells ·(unknown),Éric Richard,(unknown),Érika Hue,Anne Couroucé,B. C. McGorum,Dominic Kurian,(unknown),Stella Mazeri,Thomas M. Wishart,(unknown)	0
3	ATP-binding cassette family C member 1 constrains metabolic responses to high-fat diet in male mice 2024 ·Journal of Endocrinology ·Elisa Villalobos,(unknown),Ruth Morgan,(unknown),(unknown),Joanna Simpson,Natalie Homer,Dominic Kurian,(unknown),Rachel Kline,Thomas M. Wishart,Nicholas M. Morton,Roland H. Stimson,Ruth Andrew,Brian R. Walker,Mark Nixon	1
4	Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation 2023 ·Aging Cell ·Macarena S. Arrázola,Matías Lira,(unknown),(unknown),(unknown),Samantha L. Eaton,Douglas J. Lamont,(unknown),Gonzalo Ureta,Sebastián Bernales,César Cárdenas,Waldo Cerpa,Thomas M. Wishart,Felipe A. Court	19
5	The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo 2022 ·FEBS Journal ·(unknown),(unknown),Ruairidh Edwards,Rachel Kline,Laura C. Graham,Samantha L. Eaton,(unknown),Helena Chaytow,Yuting Huang,Ewout J. N. Groen,(unknown),Douglas J. Lamont,Kostas Tokatlidis,Thomas M. Wishart,Thomas H. Gillingwater	10
6	Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex 2022 ·Acta Neuropathologica Communications ·Zsófia I. László,(unknown),(unknown),Rachel Kline,Samantha L. Eaton,Douglas J. Lamont,Colin Smith,Tara L. Spires‐Jones,Thomas M. Wishart,Christopher M. Henstridge	24
7	An Optimized Comparative Proteomic Approach as a Tool in Neurodegenerative Disease Research 2022 ·Cells ·Rachel Kline,(unknown),Dominic Kurian,(unknown),Samantha L. Eaton,Felipe A. Court,Thomas H. Gillingwater,Thomas M. Wishart	2
8	Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment 2022 ·Cells ·Samantha L. Eaton,(unknown),Nina M. Rzechorzek,Gerard Thompson,Claudia Hartley,B. Blacklock,Chris Proudfoot,Simon Lillico,Peter W. G. Tennant,(unknown),(unknown),Paul M. Brennan,(unknown),Nadia L. Mitchell,David N. Palmer,Bruce Whitelaw,Jonathan D. Cooper,Thomas M. Wishart	4
9	The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap 2022 ·Cells ·Sharon J. Brown,Rachel Kline,Silvia A. Synowsky,Sally L. Shirran,Ian Holt,(unknown),Peter Claus,Brunhilde Wirth,Thomas M. Wishart,Heidi R. Fuller	6
10	Training associated alterations in equine respiratory immunity using a multiomics comparative approach 2022 ·Scientific Reports ·(unknown),Dominic Kurian,(unknown),Samantha L. Eaton,Thomas M. Wishart,R. S. Pirie	9
11	Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype 2019 ·Acta Neuropathologica Communications ·(unknown),Maica Llavero Hurtado,Rosemary J. Jackson,Samantha L. Eaton,Abigail G. Herrmann,Martí Colom‐Cadena,Makis Tzioras,Declan King,Jamie Rose,Jane Tulloch,Chris-Anne McKenzie,Colin Smith,Christopher M. Henstridge,Douglas J. Lamont,Thomas M. Wishart,Tara L. Spires‐Jones	59
12	Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy 2017 ·PLoS Genetics ·Penelope J Boyd,(unknown),Hannah K. Shorrock,Ewout J. N. Groen,Roderick N. Carter,Rachael A. Powis,(unknown),Derek Thomson,Laura C. Graham,(unknown),Thomas M. Wishart,J. Robin Highley,Nicholas M. Morton,Thomas Becker,Catherina G. Becker,Paul R. Heath,Thomas H. Gillingwater	72
13	Cellular and Molecular Anatomy of the Human Neuromuscular Junction 2017 ·Cell Reports ·Ross A. Jones,Carl Harrison,Samantha L. Eaton,Maica Llavero Hurtado,Laura C. Graham,(unknown),(unknown),Andrew S. Gale,Douglas J. Lamont,Hamish Simpson,Martin W. Simmen,Christian Soeller,Thomas M. Wishart,Thomas H. Gillingwater	168
14	Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture 2017 ·Molecular Neurodegeneration ·Laura C. Graham,Samantha L. Eaton,Paula J. Brunton,Abdelmadjid Atrih,Colin Smith,Douglas J. Lamont,Thomas H. Gillingwater,Giuseppa Pennetta,Paul Skehel,Thomas M. Wishart	47
15	Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation 2016 ·Expert Review of Proteomics ·Heidi R. Fuller,Laura C. Graham,Maica Llavero Hurtado,Thomas M. Wishart	17
16	WldS Prevents Axon Degeneration through Increased Mitochondrial Flux and Enhanced Mitochondrial Ca2+ Buffering 2012 ·Current Biology ·(unknown),(unknown),(unknown),Thomas M. Wishart,Thomas H. Gillingwater,James W. Geddes,Patrick G. Sullivan,Marc Freeman	121
17	Synaptic Protection in the Brain of WldS Mice Occurs Independently of Age but Is Sensitive to Gene-Dose 2010 ·PLoS ONE ·Ann K. Wright,Thomas M. Wishart,C.A. Ingham,Thomas H. Gillingwater	13
18	Protein product of CLN6 gene responsible for variant late‐onset infantile neuronal ceroid lipofuscinosis interacts with CRMP‐2 2009 ·Journal of Neuroscience Research ·Jared W. Benedict,(unknown),Thomas M. Wishart,Thomas H. Gillingwater,David A. Pearce	29
19	Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wld s ) 2008 ·Genome biology ·Thomas M. Wishart,Helen N. Pemberton,Sally James,Chris J. McCabe,Thomas H. Gillingwater	22
20	Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene 2007 ·Molecular Neurodegeneration ·Thomas M. Wishart,Stephen H.-F. Macdonald,Philip E. Chen,Michael J. Shipston,Michael P. Coleman,Thomas H. Gillingwater,Richard R. Ribchester	10

About Thomas M. Wishart

Thomas M. Wishart is a scholar working on Equine, Genetics and Cellular and Molecular Neuroscience, having authored 80 papers that have together received 3.2k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (17 papers), Alzheimer's disease research and treatments (13 papers) and RNA modifications and cancer (13 papers). The work is most often cited by research in Genetics (703 citations), Cellular and Molecular Neuroscience (951 citations) and Developmental Neuroscience (171 citations). Thomas M. Wishart has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Thomas H. Gillingwater, Samantha L. Eaton, Maica Llavero Hurtado, Simon H. Parson, Douglas J. Lamont, Karla J. Oldknow, Colin Farquharson, Sarah L. Roche, Laura C. Graham and Derek Thomson. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact